Skip to content

Author

R. Leclère

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Nov 2026

Neoadjuvant PD-L1/TGF-β blockade can rapidly disrupt the tumor stroma in head and neck cancer patients

BACKGROUND TGF-β drives fibroblast activation in cancer and is a resistance biomarker to PD-1/PD-L1 blockade. METHODS Focusing on the tumor stroma, we characterized the impact of neoadjuvant treatment with bintrafusp alfa (BA), a dual PD-L1 and TGF-β inhibitor, in a window-of-opportunity study with 6 patients with head...

Caroline Hoffmann, Jan-Timon Werle, P. Sirven et al. · 0 citations
Sep 2026

Abstract PR006: Activated ALK and MYCN drive neuroblastoma initiation through tissue-specific dynamics of neuroblast persistence and transformation

Neuroblastoma (NB) is an embryonal malignancy of the sympathetic nervous system that arises in either the adrenal gland or sympathetic ganglia. However, its developmental origin and the earliest steps of tumor initiation remain incompletely understood. We investigated how ALK activating mutations and MYCN overexp...

Nour El Houda Djerir, Amira Kramdi, Cécile Thirant et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.